Street Calls of the Week
Alignment Healthcare Inc. (NASDAQ:ALHC), a $3.27 billion healthcare company whose stock has surged 46% year-to-date, reported that CEO John E. Kao sold a total of 355,018 shares of common stock on September 10, 2025, for approximately $5,825,008. According to InvestingPro analysis, the stock is currently trading near Fair Value levels, with 8 additional key insights available to subscribers.
The sales were executed in multiple transactions with prices ranging from $16.2293 to $16.8555 per share. Specifically, 253,908 shares were sold at a weighted-average price of $16.2293, and 101,110 shares were sold at a weighted-average price of $16.8555.
Additionally, 180,000 shares held indirectly by the JEK Trust, of which Mr. Kao is the trustee, were sold at a price of $16.4164, totaling $2,954,952. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2025.
Following these transactions, Kao directly owns 4,533,568 shares and indirectly owns 1,193,100 shares of Alignment Healthcare. The company operates with moderate debt levels and has demonstrated strong momentum, with a 53% return over the past year.
In other recent news, Alignment Healthcare reported impressive second-quarter 2025 earnings, with earnings per share (EPS) coming in at $0.07, which significantly surpassed the forecast of -$0.07. The company’s revenue also exceeded expectations, reaching $1 billion compared to the projected $960.51 million, highlighting robust business growth. Following the earnings report, Barclays upgraded Alignment Healthcare’s stock from Underweight to Equalweight, raising the price target from $9.00 to $13.00. This upgrade was influenced by the company’s earnings performance, which showed revenue 6% above forecasts and EBITDA $32 million higher than anticipated for core operations.
Additionally, KeyBanc upgraded Alignment Healthcare from Sector Weight to Overweight, citing the company’s growth outlook and its effective platform that improves hospital utilization. In personnel news, Alignment Healthcare announced that Matt Eyles will join the company as executive vice president of government strategy, a new role aimed at enhancing healthcare policy engagement and business planning. These developments reflect Alignment Healthcare’s strategic initiatives and positive market reception.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.